Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol placebo-controlled crossover study of dopamine in visuospatial attention
NL-OMON26886Not yet recruiting
- Sponsor
- Utrecht University
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Haloperidol session with Placebo session (2 arms). Primary endpoints: Validity effect in the visual spatial cueing paradigm, Stop Signal Reaction Time and 6 more. Planned start Aug 2011; status: not yet recruiting.
02
Drugs
haloperidol
Beyond the preview
Go deeper on NL-OMON26886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26886.